Posts Tagged 'metal-on-metal problems'

Doctors unaware of costs associated with faulty hip devices

A survey published in Health Affairs has found that few surgeons know the costs of the devices they are implanting, including devices like the DePuy ASR hip replacement. Of the 503 physicians who took the survey, only 21% were within 20% of the correct price of devices, despite more than 80% saying it is important for surgeons to know what devices cost.

Read more about controversial DePuy hip replacements…

Hip replacements increase despite dangerous devices

More than 285,000 hip replacement surgeries took place in the United States in 2012, a 25% increase over the past five years. The increase occurred despite the number of failing metal-on-metal hip replacements, such as the BioMet M2A Magnum hip replacement.

Read more about Biomet hip replacement failure…

Federal Court Stryker Hip Claims Near 400

According to court documents, there are nearly 400 Stryker hip replacement claims pending in federal court in Minnesota. The federal consolidation was formed only six months ago and legal experts believe that additional lawsuits against hip manufacturers Stryker Corporation are to be expected.

Read more about the Stryker hip claims…

Stryker to pay $13.2 M in bribery lawsuit

Metal-on-metal hip replacement manufacturer Stryker Corporation will pay $13.2 million to settle lawsuits alleging that the company bribed doctors and governments in five different countries. The U.S. Securities and Exchange Commission (SEC) charged Stryker with masking bribes to Poland, Argentina, Greece, Mexico and Romania as “charitable donations.”

Read more about Stryker Corporation lawsuits…

NHS bans metal-on-metal hip replacements, including BioMet

The British National Health Agency (NHA) has banned metal-on-metal hip replacements of all kinds, including the BioMet M2A Magnum. The decision came after a study showed that there was a failure rate of nearly 4 out of 10 among patients fitted with the implants at NHA hospitals.

Read more about BioMet M2a Magnum failure rates…

Stryker profits down 71% due to recalls

Stryker Corporation reported 3rd-quarter profits down 71% due to ongoing issues related to its Stryker hip replacement recall. The device manufacturer issued a voluntary recall of its Stryker ABG II and Stryker Rejuvenate hip replacement in July 2012.

Read more about Stryker hip replacement issues…

BioMet Inc. buys company to enter spine market

BioMet Inc. will acquire Lanx Inc. in the attempt to break into the spinal surgery device market. BioMet is one of the primary manufacturers in the surgical device market, and manufactured the controversial BioMet M2a Magnum hip replacement.

Read more about BioMet’s controversial products…

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101


Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.